Literature DB >> 22014978

Estrogen receptor-regulated microRNAs contribute to the BCL2/BAX imbalance in endometrial adenocarcinoma and precancerous lesions.

Rong Zhang1, Yifeng He, Xueli Zhang, Baolin Xing, Youhua Sheng, Huan Lu, Zhenhong Wei.   

Abstract

Uncontrolled estrogen exposure can induce an imbalance in BCL2/BAX expression in endometrial cells, leading to precancerous lesions and type I endometrial adenocarcinoma. This study aimed to explore the mechanism underlying this phenomenon. We show that the activated estrogen receptor can suppress the expression of BAX by upregulating a group of microRNAs including hsa-let-7 family members and hsa-miR-27a, thereby promoting an increased BCL2/BAX ratio as well as enhanced survival and proliferation in the affected cells. These ER-regulated hsa-let-7 microRNAs can be detected in most hyperplastic endometria, suggesting their potential utility as indicators of estrogen over-exposure.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22014978     DOI: 10.1016/j.canlet.2011.09.027

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  16 in total

Review 1.  Non-coding RNAs in Uterine Development, Function and Disease.

Authors:  Warren B Nothnick
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

2.  miR-200a/miR-141 and miR-205 upregulation might be associated with hormone receptor status and prognosis in endometrial carcinomas.

Authors:  Ying Dong; Jing-Wen Si; Wen-Ting Li; Li Liang; Jian Zhao; Mei Zhou; Dong Li; Ting Li
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

3.  Imiquimod Induces Apoptosis in Human Endometrial Cancer Cells In vitro and Prevents Tumor Progression In vivo.

Authors:  Aliyah Almomen; Elke A Jarboe; Mark K Dodson; C Matthew Peterson; Shawn C Owen; Margit M Janát-Amsbury
Journal:  Pharm Res       Date:  2016-05-31       Impact factor: 4.200

Review 4.  Molecular cues on obesity signals, tumor markers and endometrial cancer.

Authors:  Danielle Daley-Brown; Gabriela M Oprea-Ilies; Regina Lee; Roland Pattillo; Ruben R Gonzalez-Perez
Journal:  Horm Mol Biol Clin Investig       Date:  2015-01

Review 5.  miRNAs and estrogen action.

Authors:  Carolyn M Klinge
Journal:  Trends Endocrinol Metab       Date:  2012-04-11       Impact factor: 12.015

Review 6.  Non-Coding RNAs in Endometrial Physiopathology.

Authors:  Alessandro La Ferlita; Rosalia Battaglia; Francesca Andronico; Salvatore Caruso; Antonio Cianci; Michele Purrello; Cinzia Di Pietro
Journal:  Int J Mol Sci       Date:  2018-07-20       Impact factor: 5.923

Review 7.  Aberrant regulation of the LIN28A/LIN28B and let-7 loop in human malignant tumors and its effects on the hallmarks of cancer.

Authors:  Tianzhen Wang; Guangyu Wang; Dapeng Hao; Xi Liu; Dong Wang; Ning Ning; Xiaobo Li
Journal:  Mol Cancer       Date:  2015-06-30       Impact factor: 27.401

Review 8.  miRNAs regulated by estrogens, tamoxifen, and endocrine disruptors and their downstream gene targets.

Authors:  Carolyn M Klinge
Journal:  Mol Cell Endocrinol       Date:  2015-02-03       Impact factor: 4.102

9.  Circulating miRNA 27a and miRNA150-5p; a noninvasive approach to endometrial carcinoma.

Authors:  Rasha Abdelmawla Ghazala; Eman Ahmed El-Attar; Ziad Sami Abouzeid
Journal:  Mol Biol Rep       Date:  2021-06-02       Impact factor: 2.316

10.  A CREB1-miR-181a-5p loop regulates the pathophysiologic features of bone marrow stromal cells in fibrous dysplasia of bone.

Authors:  Yu Fu; Zhili Xin; Ziji Ling; Hanyu Xie; Tao Xiao; Xin Shen; Jialin Lin; Ling Xu; Hongbing Jiang
Journal:  Mol Med       Date:  2021-07-22       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.